跳至主要内容
临床试验/IRCT20210925052566N2
IRCT20210925052566N2尚未招募3 期

The effects of nano curcumin supplementation in diabetic peripheral neuropathy

ational Institute for Medical Research Development0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Patients will eligible for recruitment with a MNSI of 2 or higher, abnormal NCS results and normal folate, vitamin B12 levels.

排除标准

  • Exclusion criteria will be uncontrolled diabetes (HbA1c>8.5%), current pregnancy or lactating women, alcohol intake, current smoker, diabetic foot , mental disease, heart failure, cancer, evidence of liver disease (such as viral hepatitis, autoimmune hepatitis, etc.), impaired renal (GFR < 30), sensitivity to turmeric supplementation, current use of warfarin or other anticoagulant agents, and those with symptomatic peripheral vascular disease.

研究者

发起方
ational Institute for Medical Research Development

相似试验